GK2

GK2 was identified as a candidate galactokinase through its ability to functionally complement a galactokinase-deficient (gal1−) yeast strain, restoring in vivo galactokinase activity and indicating that the encoded 458-amino-acid protein can substitute for yeast galactokinase (PMID:1438294). However, when expressed in mammalian COS cells, GK2 produced no detectable galactokinase activity despite confirmed mRNA expression, while a control galactokinase construct was active under the same conditions (PMID:7542884). The enzymatic function and physiological role of GK2 in mammalian cells therefore remain uncharacterized in the available corpus; beyond the yeast complementation and the negative mammalian activity assay, no substrate, interacting partner, localization, or pathway role has been established.

1. 1992 Medium

   Whether the GK2 gene product had any galactokinase function was unknown; isolating the cDNA by rescuing a galactokinase-deficient yeast strain established that GK2 can functionally substitute for galactokinase in vivo and is genetically distinct from GK1.

   Evidence Yeast complementation of gal1− mutant with human cDNA library plus chromosomal mapping

   PMID:1438294

   Open questions at the time

   • Complementation in yeast does not demonstrate galactokinase activity in mammalian cells
   • No direct biochemical measurement of enzyme kinetics or substrate specificity
   • Physiological role and tissue context in humans not addressed
2. 1995 Medium

   Whether GK2 acts as a galactokinase in a mammalian setting was tested directly; expression in COS cells yielded no detectable galactokinase activity despite confirmed transcription, showing GK2 does not function as a galactokinase under these conditions and leaving its biochemical role unresolved.

   Evidence Transient expression in COS cells with galactokinase enzymatic activity assay and Northern blot mRNA confirmation

   PMID:7542884

   Open questions at the time

   • Negative result may reflect missing cofactors, post-translational modification, or improper folding in COS cells rather than absence of intrinsic activity
   • No alternative substrate tested
   • Endogenous tissue-specific expression and function not examined

• The native enzymatic activity, true substrate, subcellular localization, and physiological function of mammalian GK2 remain undefined.
• No purified-protein biochemistry to define catalytic activity or kinetics
• No identified physical partners or pathway placement
• No in vivo or knockout phenotype data